Content Detail

• Content META

  Title	Owens & Minor Reports Second Quarter 2025 Financial Results
  ID	12391623
  External ID	7957078590
  Author	Unknown
  Published Date	Aug. 11, 2025, 5:44 a.m.
  Summary	Owens & Minor, Inc. (NYSE: OMI)today reported financial results for the second quarter ended June 30, 2025. In connection with a likely sale of the Company's Products & Healthcare Services segment, th
  Tags	None
  URL	https://www.ariva.de/aktien/owens-minor-aktie/news/owens-minor-reports-second-quarter-2025-financial-results-11720489
  Sentiment	Negative: 0.01397    Neutral: 0.88519    Positive: 0.10084
  Relevance	0.03292

• Content Details

  Content ID	7912630
  Key	aed13d96-600a-4543-acf1-bc286d1c55c6
  Content	Owens & Minor, Inc. (NYSE: OMI)today reported financial results for the second quarter ended June 30, 2025. In connection with a likely sale of the Company's Products & Healthcare Services segment, the results herein, unless otherwise noted, reflect the Company's continuing operations which primarily represent what was previously the Patient Direct segment and certain functional operations. Anhören Teilen Feedback Kopieren “We are in the final stages of our robust process for the divestiture of the Products & Healthcare Services segment, and, as a result, have classified this segment as discontinued operations. We are looking forward to concluding the sale of the business and working with a buyer who has the vision and greater flexibility to better support our customers and long-term growth,” said Ed Pesicka, Owens & Minor's Chief Executive Officer. Mr. Pesicka concluded, “I am excited about the opportunities ahead as we transition into a focused, pure-play Patient Direct business. Building on the momentum gained since we entered the Patient Direct space eight years ago, and supported by favorable demographic trends and meaningful scale, we are confident in our ability to lead as the market continues to evolve.” Second Quarter Results ($ in millions, except per share data) YTD YTD 2Q25 2Q24 Revenue Loss from continuing operations, net of tax, GAAP Adj. net income from continuing operations, Non-GAAP Adj. EBITDA, Non-GAAP Loss from continuing operations, net of tax per common share, GAAP Adj. net income from continuing operations per share, Non-GAAP Reconciliations of the differences between the non-GAAP financial measures presented in this release and their most directly comparable GAAP financial measures are included in the tables below. 2025 Continuing Operations Financial Outlook The Company will provide its 2025 financial outlook for continuing operations during its earnings conference call this morning at 8:30 a.m. EDT. Investor Conference Call for Second Quarter 2025 Financial Results Owens & Minor will host a conference call for investors and analysts on Monday, August 11, 2025, at 8:30 a.m. EDT. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Owens & Minor website available at investors.owens-minor.com/events-and-presentations/. A replay of the webcast can be accessed following the presentation at the link provided above. Safe Harbor This release is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This release contains certain “forward looking” statements made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, the statements in this release regarding our future prospects and performance, including our expectations with respect to our financial performance, our 2025 financial results, Owens & Minor's ability to successfully complete the sale of the P&HS business in any specific transaction on favorable terms or at all, our cost saving initiatives, future indebtedness and growth, industry trends, as well as statements related to our expectations regarding the performance of our business, including our ability to address macro and market conditions. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. Investors should refer to Owens & Minor's Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on February 28, 2025, including the section captioned “Item 1A. Risk Factors,” as applicable, and subsequent quarterly reports on Form 10-Q and current reports on Form 8-K filed with or furnished to the SEC, for a discussion of certain known risk factors that could cause the Company's actual results to differ materially from its current estimates. These filings are available at www.owens-minor.com . Given these risks and uncertainties, Owens & Minor can give no assurance that any forward-looking statements will, in fact, transpire and, therefore, cautions investors not to place undue reliance on them. Owens & Minor specifically disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise. About Owens & Minor Owens & Minor, Inc. (NYSE: OMI) is a Fortune 500 global healthcare solutions company providing essential products and services that support care from the hospital to the home. For over 100 years, Owens & Minor and its affiliated brands, Apria®, Byram® and HALYARD*, have helped to make each day better for the patients, providers, and communities we serve. Powered by more than 20,000 teammates worldwide, Owens & Minor delivers comfort and confidence behind the scenes so healthcare stays at the forefront. Owens & Minor exists because every day, everywhere, Life Takes Care™. For more information about Owens & Minor and our affiliated brands, visit owens-minor.com or follow us on LinkedIn and Instagram. * Registered Trademark or Trademark of O&M Halyard or its affiliates. Owens & Minor, Inc. Consolidated Statements of Operations (unaudited) (dollars in thousands, except per share data) Three Months Ended June 30, Net revenue Operating costs and expenses: Cost of net revenue Selling, general and administrative expenses Transaction breakage fee — Acquisition-related charges and intangible amortization Exit and realignment charges, net Total operating costs and expenses Operating (loss) income Interest expense, net Transaction financing fees, net — Other expense, net Loss from continuing operations before income taxes Income tax benefit Loss from continuing operations, net of tax Loss from discontinued operations, net of tax Net loss Basic loss per common share Loss from continuing operations, net of tax Loss from discontinued operations, net of tax Net loss Diluted loss per common share Loss from continuing operations, net of tax Loss from discontinued operations, net of tax Net loss Owens & Minor, Inc. Consolidated Statements of Operations (unaudited) (dollars in thousands, except per share data) Six Months Ended June 30, Net revenue Operating costs and expenses: Cost of net revenue Selling, general and administrative expenses Transaction breakage fee — Acquisition-related charges and intangible amortization Exit and realignment charges, net Total operating costs and expenses Operating (loss) income Interest expense, net Transaction financing fees, net — Other expense, net Loss from continuing operations before income taxes Income tax benefit Loss from continuing operations, net of tax Loss from discontinued operations, net of tax Net loss Basic loss per common share Loss from continuing operations, net of tax Loss from discontinued operations, net of tax Net loss Diluted loss per common share Loss from continuing operations, net of tax Loss from discontinued operations, net of tax Net loss Owens & Minor, Inc. Condensed Consolidated Balance Sheets (unaudited) (dollars in thousands) June 30, 2025 December 31, 2024 Assets Current assets Cash and cash equivalents Accounts receivable, net Inventories Other current assets Current assets of discontinued operations Total current assets Patient service equipment and other fixed assets, net Operating lease assets Goodwill Intangible assets, net Other assets, net Noncurrent assets of discontinued operations — Total assets Liabilities and equity Current liabilities Accounts payable Accrued payroll and related liabilities Current portion of long-term debt Other current liabilities Current liabilities of discontinued operations Total current liabilities Long-term debt, excluding current portion Operating lease liabilities, excluding current portion Deferred income taxes, net Other liabilities Noncurrent liabilities of discontinued operations — Total liabilities Total (deficit) equity Total liabilities and equity Owens & Minor, Inc. Consolidated Statements of Cash Flows (unaudited) (dollars in thousands) Three Months Ended June 30, Operating activities: Net loss Adjustments to reconcile net loss to cash provided by operating activities: Depreciation and amortization Goodwill impairment charge — Loss on classification to held for sale — Share-based compensation expense Deferred income tax benefit Changes in operating lease right-of-use assets and lease liabilities Gain from sale and dispositions of patient service equipment and other fixed assets Changes in operating assets and liabilities: Accounts receivable, net
  Content Reference URL	None

• Publisher

  Publisher Name	Ariva.de (#6141)
  Publisher URL	https://www.ariva.de
  Description	None
  Trust Flow Score	60
  Citation Flow Score	45

• Data Source

  Data Source Name	Quantexa News (#5)
  Data Source Type	news
  Data Source URL	https://app.aylien.com/dashboard
  Description	Welcome to Quantexa News API — the most powerful way to aggregate, filter, and integrate global news data into your apps and models.
  Weight	10